Last update 15 May 2025

NSL-95301

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NSL-95301
Target
GP IIb/IIIa
Action
antagonists
Mechanism
GP IIb/IIIa antagonists(Integrin alpha-IIb/beta-3 antagonists)
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesOther Diseases
Active Indication-
Inactive Indication
Angina PectorisMyocardial InfarctionPerioperative ischaemia+ [1]
Originator Organization
NIPPON STEEL CORP.NIPPON STEEL CORP.
Active Organization-
Inactive Organization
NIPPON STEEL CORP.NIPPON STEEL CORP.
License Organization-
Drug Highest PhasePendingDiscovery
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC26H32N4O4
InChIKeyUPZSBIRXZBWTNA-UHFFFAOYSA-N
CAS Registry180180-51-2

Related

100 Clinical Results associated with NSL-95301
Login to view more data
100 Translational Medicine associated with NSL-95301
Login to view more data
100 Patents (Medical) associated with NSL-95301
Login to view more data
3
Literatures (Medical) associated with NSL-95301
01 Jan 1997BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Development of the new potent non-peptide gpIIb/IIIa antagonist NSL-95301 by utilizing combinatorial technique
Development of the new potent non-peptide GpIIb/IIIa antagonist NSL-95301 by utilizing combinatorial idea
Development of potent non-peptide GPIIb/IIIa antagonists with tri-substituted β-amino acid derivatives as a new conformational restriction unit
100 Deals associated with NSL-95301
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Angina PectorisDiscovery
Japan
NIPPON STEEL CORP.NIPPON STEEL CORP.
-
Myocardial InfarctionDiscovery
Japan
NIPPON STEEL CORP.NIPPON STEEL CORP.
-
Perioperative ischaemiaDiscovery
Japan
NIPPON STEEL CORP.NIPPON STEEL CORP.
-
StrokeDiscovery
Japan
NIPPON STEEL CORP.NIPPON STEEL CORP.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free